Rechercher | Wagerhaus

Sarthak Jain Ajouter une nouvelle offre d'emploi Health
2026-07-31 11:33:23 -

Bispecific Antibody Therapeutics: The Evolving Targeted Immunotherapy Market
The management of cancer has been transformed by advances in immunotherapy, with bispecific antibody therapeutics emerging as a key treatment modality. Bispecific antibody therapeutics offer a novel approach to engaging the immune system, providing targeted cell elimination with the potential for durable responses. The cell bridging bispecific antibodies market is experiencing...

0 Commentaires 0 Parts 16 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Sarthak Jain Ajouter une nouvelle offre d'emploi Health
2026-07-14 13:35:33 -

Precision Biologics: How Monoclonal Antibody Therapeutics Are Targeting Iron Metabolism
The Hemojuvelin Monoclonal Antibody Market is experiencing significant growth as monoclonal antibody therapeutics continue to target iron metabolism and related disorders. According to market reports, the global Hemojuvelin Monoclonal Antibody Market was valued at USD 400 million in 2024 and is projected to reach USD 1,500 million by 2035, exhibiting an impressive CAGR of 13.4% during...

0 Commentaires 0 Parts 96 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Vanshika Swami Ajouter une nouvelle offre d'emploi Health
2026-05-21 10:13:00 -

North America Hyperimmune Globulin Market Trends and Forecast 2031
The hyperimmune globulin market is experiencing strong growth due to the rising demand for plasma-derived therapies and increasing awareness regarding immunological treatment solutions. Hyperimmune globulins are highly concentrated antibody products derived from human plasma and are widely used for infection prevention, post-exposure prophylaxis, and immune deficiency treatment. The growing...

0 Commentaires 0 Parts 383 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Subhayan Mayra Ajouter une nouvelle offre d'emploi Autre
2026-06-12 10:21:01 -

United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034
The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...

0 Commentaires 0 Parts 432 Vue 0 Aperçu

Connectez-vous pour aimer, partager et commenter!